BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20150642)

  • 1. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.
    Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I
    Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa.
    Takano H; Shibata T; Nakamura M; Sakurai N; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Otsuka T; Tahara T; Arisawa T
    BMC Med Genet; 2020 Oct; 21(1):205. PubMed ID: 33066747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Dig Dis Sci; 2010 Dec; 55(12):3449-57. PubMed ID: 20397048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
    Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
    Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk.
    Kaise M; Yamasaki T; Yonezawa J; Miwa J; Ohta Y; Tajiri H
    Helicobacter; 2008 Feb; 13(1):35-41. PubMed ID: 18205664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer.
    Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO
    Digestion; 2006; 74(2):85-90. PubMed ID: 17139167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa.
    Tahara T; Shibata T; Yamashita H; Nakamura M; Yoshioka D; Okubo M; Hirata I; Arisawa T
    Cancer Sci; 2009 Jul; 100(7):1192-7. PubMed ID: 19432886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Int J Mol Med; 2010 Mar; 25(3):471-7. PubMed ID: 20127054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polymorphisms of IL-1β and TNF-α genes on CpG island hyper methylation (CIHM) in the nonneoplastic gastric mucosa.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Hirata I; Arisawa T
    Mol Carcinog; 2011 Nov; 50(11):835-45. PubMed ID: 21400614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
    Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J
    Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Int J Mol Med; 2009 Oct; 24(4):563-9. PubMed ID: 19724898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium.
    Nomura T; Tahara T; Shiroeda H; Minato T; Matsue Y; Hayashi R; Matsunaga K; Otsuka T; Nakamura M; Toshikuni N; Shibata T; Arisawa T
    BMC Gastroenterol; 2013 Jan; 13():1. PubMed ID: 23280118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; Amiñoso C; de Campos JM; Sarasa JL; Gutierrez M; Rey JA
    Cancer Genet Cytogenet; 2003 Apr; 142(1):21-4. PubMed ID: 12660028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTHFR 677T carrier influences the methylation status of H. pylori-infected gastric mucosa in older subjects.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Takahama K; Watanabe M; Hirata I; Arisawa T
    Dig Dis Sci; 2009 Nov; 54(11):2391-8. PubMed ID: 19082889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.
    Wu PY; Zhang Z; Wang JM; Guo WW; Xiao N; He Q; Wang YP; Fan YM
    World J Gastroenterol; 2012 Jan; 18(1):70-8. PubMed ID: 22228973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation status of nine tumor suppressor genes in multiple myeloma.
    Braggio E; Maiolino A; Gouveia ME; Magalhães R; Souto Filho JT; Garnica M; Nucci M; Renault IZ
    Int J Hematol; 2010 Jan; 91(1):87-96. PubMed ID: 20037750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island methylation in premalignant stages of gastric carcinoma.
    Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
    Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.